IlluminOss Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

IlluminOss Medical is a private medical device company pioneering a novel, minimally invasive approach to fracture repair, particularly for patients with osteoporosis or bone metastases. Its core technology involves a light-curable polymer contained within a balloon catheter, which is inserted into the intramedullary canal and hardened to provide internal stabilization. The system is designed to reduce surgical trauma, operative time, and blood loss compared to traditional metal plates and screws. With a focus on geriatric and pathologic fractures, IlluminOss targets a growing patient population with significant unmet clinical need.

OrthopedicsTrauma

Technology Platform

A photodynamic bone stabilization system using a light-curable polymer within a balloon catheter to create a patient-conforming intramedullary implant for fracture fixation.

Funding History

2

Series BUndisclosedUndisclosedJun 15, 2017

Series AUndisclosedUndisclosedJun 15, 2015

Opportunities

The aging global population and rising prevalence of osteoporosis and bone metastases create a large and growing addressable market for minimally invasive fracture solutions.

The system's versatility across multiple bones allows for a broader commercial strategy within a single platform.

There is a significant opportunity for partnership or acquisition by a large orthopedic company seeking innovative technology in this niche.

Risk Factors

Commercial success depends on overcoming surgeon inertia and training them on a new technique, which can be slow.

Securing favorable and consistent reimbursement from payers is a persistent challenge for novel medical devices.

Competition from large, well-capitalized orthopedic incumbents with deep market access poses a constant threat.

Competitive Landscape

IlluminOss competes in the orthopedic fracture fixation market, which is dominated by large players like Stryker, DePuy Synthes (J&J), Zimmer Biomet, and Smith & Nephew. These companies offer traditional metal plates, screws, nails, and intramedullary rods. IlluminOss's primary competitive differentiation is its minimally invasive, conformable, polymer-based approach, which targets a specific subset of patients (geriatric/pathologic) where metal fixation is often problematic. Other competitors may include companies offering bone cement augmentation or emerging biomaterial-based solutions.

More companies in Regenerative Medicine →More companies in Germany →